18F-FDG PET/CT versus bone scintigraphy in the follow-up of gastric cancer

M. Sollini, L. Calabrese, B. Zangheri, P. A. Erba, A. Gramaglia, M. Gasparini

Research output: Contribution to journalArticlepeer-review


A 53-year-old patient underwent a positron emission tomography/computed tomography with 2-fluoro-2-deoxy-d-glucose (18F-FDG PET/CT) in the suspicious of gastric tumor recurrence (mediastinal and abdominal lymph nodes). PET/CT identified only an area of 18F-FDGuptake in the twelfth thoracic vertebrae. Unexpectedly, a bone scintigraphy revealed many "hot" spots changing the diagnosis (single metastasis versus plurimetastatic disease) and impacting on patient's management.

Original languageEnglish
Pages (from-to)121-123
Number of pages3
JournalRevista Espanola de Medicina Nuclear e Imagen Molecular
Issue number2
Publication statusPublished - Mar 1 2016


  • 2-Deoxy-2-(F)fluoro-d-glucose positron emission tomography/computed tomography
  • Bone scintigraphy
  • Gastric cancer

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of '18F-FDG PET/CT versus bone scintigraphy in the follow-up of gastric cancer'. Together they form a unique fingerprint.

Cite this